Equine Healthcare Market Size Expected to reach $2.33 Billion by 2030

Equine healthcare market was valued at $1,206.70 billion in 2020, and is projected to reach $2,328.90 billion by 2030, registering a CAGR of 6.80% from 2021 to 2030. Horses need proper care after a hard workout to help with cool-down and recovery. There are multiple areas to pay close attention to after a ride such as body temperature, respiration, muscle care, and leg condition. Equine healthcare helps to recognize the things when it gets bad for the health of the horses. In addition to properly feeding and exercising one's horse, other aspects of general care are needed to keep the horse healthy throughout his or her life.
These include routine veterinary care for vaccinations, parasite control, and dental care; grooming and hoof care; and protection from the elements. Horses must be regularly monitored for the sign of illness that include lack of appetite, diarrhea, coughing, and sneezing, or discharge from the eyes or nose, loss of hair or itchy areas on the skin, lameness (such as not putting weight on a particular leg), and reluctance to move or head bobbing.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Key players operating in the global equine healthcare market include Thermo Fisher Scientific (Affymetrix), Elanco Animal Health (Bayer Animal Health), Boehringer Ingelheim, Ceva Sante Animale, Land o Lakes(Purina Mills LLC), Equine Products UK Ltd, Merck & Co.(Merck Animal Health), Sanofi S.A. (Merial), Vetoquinol S.A., and Zoetis.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/387

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:
The COVID-19 pandemic affected the equine healthcare industry in a negative way similar to various other domestic industries. Some governments mandated the closure of equine facilities to reduce the spread of the virus and minimize risks of injury while others delegated responsibility to equine enterprise owners and managers. The complete closure of equine facilities has been especially damaging, as these operations bear significant ongoing expenses with no source of revenue. Increasing unemployment rates in the initial days lead to increase in problems associated with equine welfare.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/387

On the basis of products type, the market is categorized into drug, vaccines, and medicated feed additives. The drug segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. The key factors, such as rise in demand for pet insurance, surge in awareness toward effective & advanced drugs and vaccines, and rise in number of cases of equine diseases may lead to increase in hospital admissions. Launch of effective products, which are tested under clinical trials by companies, ensures better therapeutic outcomes.

On the basis of disease, the market is segregated into influenza, tetanus, equine herpes virus, and others. At present, the others segment accounts for a majority of the market share, owing to rise in prevalence of equine diseases in both developed as well as developing countries and surge in demand for pet insurance that would help the segment generate higher revenue shares in the coming years.

On the basis of distribution channel, the market is segregated into veterinary hospitals and clinics and retail pharmacies and drug stores. At present, the retail pharmacies and drug stores segment accounts for the majority of market share, owing to rise in prevalence of equine diseases in both developed as well as developing countries and growing awareness among the population about the importance and benefits of horses healthcare.

North America has the highest market share of the global equine healthcare market in 2020, followed by other regions. The larger share of the North America region can be attributed to factors such as ease of availability of devices and services across developing countries and rise in health awareness among people. Overall, it is projected that the need for equine healthcare in developing and developed regions of North America would rise sharply in the coming years.

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

• By product type, the drugs segment was the highest contributor to the market, with $788.80 million in 2020, and is estimated to reach $1,515.50 million by 2030, at a CAGR of 6.70%.
• By diseases, the others segment was the highest contributor to the market, with $508.20 million in 2020, and is estimated to reach $908.80 million by 2030, at a CAGR of 5.90%.
• By distribution channel, the retail pharmacies and drug stores segment was the highest contributor to the market, with $693.60 million in 2020, and is estimated to reach $1,366.60 million by 2030, at a CAGR of 7.00%.
• North America is expected to be the fastest growing region, registering a CAGR of 5.90% during the forecast period.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Surgical Clips Market -- https://www.alliedmarketresearch.com/surgical-clips-market

Urinary Tract Cancer Market -- https://www.alliedmarketresearch.com/urinary-tract-cancer-market

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.